Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > Must be some really pizzed warrant holders out there
View:
Post by mdjbrown on Mar 06, 2023 7:21pm

Must be some really pizzed warrant holders out there

TORONTOMarch 6, 2023 /CNW/ - The following issues have been halted by IIROC:

Company: MediPharm Labs Corp.

TSX Symbol: LABS.WT

All Issues: No

Reason: Pending Delisting

Comment by subaru1 on Mar 07, 2023 10:59am
This is a confirmation that management doesn't beleive to much in the evolution of the company for the coming year, too bad..I am one of the guys who got screw with this warrants.
Comment by mdjbrown on Mar 08, 2023 9:17am
subaru1, it is puzzling why Medipharm did not extend the warrants for anoher 12 months. If the shareprice reached .70 cents within a years extension, an additional $35 million could have been realized. If these guys announce a dilutive private placement in the next 12 months, pink slips should follow!  
Comment by corvette67 on Mar 08, 2023 12:39pm
They could have extended 3 years and they would still be worthless. This thing is just roadkill. GLTA
Comment by Stonksonlyup90 on Mar 08, 2023 2:35pm
Why waste resources ($ and time) to extend/re-price?! Past mistakes shouldn't be given attention - they have the funds to execute and pending acquisition setting company up for future growth.  The shares can be bought on the open market for exposure.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities